Dario Smart Diabetes Management Solution

Rodman & Renshaw analyst Raghuram Selvaraju believes LabStyle Innovations Corp (NASDAQ: DRIO) could more than double in a year from the current levels. The brokerage initiated coverage with a rating of Buy and a price target of $12.00 on valuation. The optimism was due to the development of an...